This approach, along with the increasingly popular practice of cold exposure, is reshaping the pharma and wearable industry’s understanding of how to optimize physiological and mental well-being. Extreme athlete Wim Hof has lauded the potential of these methods, emphasizing their profound impact on human health.
Parasym, a pioneering neurotechnology company has introduced Nurosym, a wearable medical device designed to modulate the nervous system. Through targeted electrical signals delivered to the brain via the vagus nerve, Nurosym offers a novel approach to addressing a wide range of health conditions associated with autonomic nervous system imbalance.
Backed by partnerships with respected institutions such as Harvard and UCL, Parasym says it has conducted extensive research demonstrating the efficacy of neuromodulation in managing chronic stress, fatigue, autoimmune disorders, migraines, anxiety, and more.
The company says its auricular vagal neuromodulation therapy (AVNT), delivered through the Nurosym device, enhances the body’s ‘rest and digest’ response, promoting feelings of calmness and safety while alleviating stress and fatigue.
Clinical trials have shown that Nurosym can rapidly increase parasympathetic activity by an impressive 50% within just five minutes, offering a breakthrough in stress relief methods. In comparison, cold water immersion, often used for similar purposes, has been likened to the effect of roughly 100 ice baths, albeit with less predictability and requiring repeated exposure over time.
Crucially, the company says neuromodulation differs from cold exposure by directly targeting specific therapeutic mechanisms in the body, as demonstrated in randomized double-blind placebo-controlled clinical trials. This approach yields significant and enduring benefits for health and performance, with bioelectric-induced improvements increasing over time due to a physiological memory effect.
It says the benefits of AVNT extend beyond stress relief, encompassing enhanced parasympathetic activity, increased heart rate variability (HRV), and inflammation reduction. Clinical studies have shown a remarkable 78% decrease in inflammation among individuals with serious heart problems during a short hospital stay.
The company believes Nurosym represents a groundbreaking advancement in bioelectric medicine, offering a CE-certified medical device that has already facilitated over 3,000,000 treatment sessions. With endorsements from Olympic athletes like Joel Naukkarinen and public figures like Bryan Johnson, Nurosym, the company says, is poised to revolutionize health and wellness, empowering individuals to optimize their well-being with cutting-edge wearable medical technology.
Parasym’s significant contributions to the field of medicine have garnered international recognition, earning them a place among the ‘Top 20 Medical Device Companies To Watch.’ The company’s groundbreaking work has been featured and reviewed in prominent publications like The Guardian, solidifying their position at the forefront of healthcare innovation.
